Bright Minds Biosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bright Minds Biosciences Inc
TickerDRUG
CIK #0001827401
CUSIP10919W405
SectorLife Sciences - Pharmaceutical Preparations
Address19 Vestry Street, New York, NY 10013
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Bright Minds Biosciences Inc 2024-11-19 34.6 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001827401] 3
[0001827401] 4
[0001827401] 6-K
[0001827401] D
[0001827401] SC 13D
[0001827401] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Bright Minds Biosciences Inc [2026-05-15] 0.0
Vivo Opportunity Fund Holdings LP Bright Minds Biosciences Inc [2025-11-14] 0.0
Adage Capital Management LP Bright Minds Biosciences Inc [2025-11-13] 0.0
SIO Capital Management LLC Bright Minds Biosciences Inc [2025-04-08] 0.0
SIO Capital Management LLC Bright Minds Biosciences Inc [2025-02-10] 0.0
Janus Henderson Group PLC Bright Minds Biosciences Inc [2025-02-07] 0.0
RA Capital Management LP Bright Minds Biosciences Inc [2024-11-12] 6.6
Commodore Capital LP Bright Minds Biosciences Inc [2024-10-25] 0.0
Point72 Asset Management LP Bright Minds Biosciences Inc [2024-10-23] 0.7
Logos Global Management LP Bright Minds Biosciences Inc [2024-10-23] 2.2
Cormorant Asset Management LP Bright Minds Biosciences Inc [2024-10-22] 18.79
Perceptive Advisors LLC Bright Minds Biosciences Inc [2024-10-16] 81949.6
McDonald Ian Bright Minds Biosciences Inc [2024-01-18] 7.57
Form 3/4/5 Filer 2011 - 2026
Cormorant Global Healthcare Master Fund LP
Cormorant Asset Management LP
Chen Bihua
Bright Minds Biosciences Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Cormorant Asset Management LP +1
Common Shares
 2024-11-04 Buy 184,331 $21.70 3,999,983
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-16 Buy 7,150 $24.03 171,814
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-16 Buy 39,743 $23.22 922,832
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-16 Buy 3,107 $25.22 78,359
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 63,173 $5.92 373,984
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 33,343 $6.42 214,062
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 8,900 $7.31 65,059
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 2,600 $8.80 22,880
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 2,700 $9.26 25,002
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 19,169 $11.72 224,661
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 4,609 $12.35 56,921
Cormorant Global Healthcare Master Fund LP +2
Common Shares
 2024-10-15 Buy 238,097 $4.53 1,078,579
13F Ownership Over TimeHoldersShares Held
2026-03-31 94 9,188,601
2025-12-31 74 6,590,203
2025-09-30 64 6,046,060
2025-06-30 49 5,236,821
2025-03-31 35 5,203,844
2024-12-31 32 4,897,032
2024-09-30 7 191,547
2024-06-30 7 197,540
2024-03-31 8 213,375
2023-12-31 9 228,360
2023-09-30 7 194,601
2023-06-30 9 573,730
Form 13F Holdings
Firm Period DFND Voting Shares
Gamma Investing LLC [2026-06-30] DFND 20 20
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com